Development of Magnetic Resonance Spectroscopic Imaging Techniques for Imaging Metabolites in Human Brain and Muscle
-
- STATUS
- Recruiting
-
- End date
- Oct 23, 2026
-
- participants needed
- 300
-
- sponsor
- National Institute of Mental Health (NIMH)
Summary
- Background
-
- Magnetic resonance imaging (MRI) is a widely used scanning technique to obtain images of
the human body and evaluate activity in the brain. A particular MRI method called magnetic
resonance spectroscopy (MRS) can be used to study brain chemistry as well, which may help
researchers who are studying new treatments for psychiatric illnesses. Researchers are
interested in improving current MRI and MRS techniques, as well as developing new MRI and MRS
techniques to view and measure brain chemicals and brain activity.
- Objectives
- To implement, develop, and optimize brain chemistry imaging techniques using magnetic
resonance imaging and magnetic resonance spectroscopy.
- Eligibility
- Healthy individuals between 18 and 65 years of age.
- Design
- This study will involve a screening visit and a scanning visit at the National Institutes of Health Clinical Center.
- Participants will be screened with a full medical and physical examination, blood and urine tests, and neurological testing.
- During the second visit, participants will have an MRI scan of the brain. (Participants who have received an MRI within the past year will not need to have a second one; the images of the previous scan will be used for this study.) All participants will then have an MRS scan using the same scanning equipment.
- Magnetic resonance imaging (MRI) is a widely used scanning technique to obtain images of
the human body and evaluate activity in the brain. A particular MRI method called magnetic
resonance spectroscopy (MRS) can be used to study brain chemistry as well, which may help
researchers who are studying new treatments for psychiatric illnesses. Researchers are
interested in improving current MRI and MRS techniques, as well as developing new MRI and MRS
techniques to view and measure brain chemicals and brain activity.
Description
Magnetic resonance spectroscopy (MRS) is identical to MRI except that the metabolite signal, rather than the dominant water signal, is measured. Proton (1H) MRS and phosphorous (P) MRS are two powerful spectroscopy methods to measure metabolism in vivo.
By using water suppression techniques, proton MRS can monitor levels of important brain metabolites and neurotransmitters such as N-acetylaspartate (NAA), creatine, choline, lactate, myo-inositol, glutamate, glutamine, gamma aminobutyric acid (GABA), and glutathione.
P MRS can be utilized to measure energy phosphate metabolites of inorganic phosphate (Pi), phosphocreatine (PCr), adenosine diphosphate (ADP), and adenosine triphosphate (ATP) in brain and muscle. In addition, phosphocholine (PC), phosphoethanolamine (PE), glycerophosphocholine (GPC) and glyceophosphoethanolamine (GPE) can also be detected in brain tissues.<TAB>
This protocol proposes three main goals. First, to implement and optimize current proton and P MRS methods published in the literature for the imaging of metabolites in human brain and muscle. Second, to further develop new methods for use in similar brain and muscle MRS applications. Third, to exchange MRS data with other studies in order to provide data analysis and quality control for the studies under this, other NIH, or outside protocols.
To develop and optimize in vivo MRS methods, 300 healthy volunteers will be recruited over a period of ten years. The subjects will be aged 18-65 years, and include representative numbers of males, females, and minorities.
The experiments will be performed on the GE 3T, Siemens 3T and 7T MRI scanners located at the NIH In Vivo NMR Research Center. In the first portion of the study, a clinical MRI will be performed to ensure the subject has no abnormal brain conditions. In the second portion of the study, MRS scans will be performed in various system and pulse parameter combinations. No medications will be involved. Total scan time during the MRS scan will be one to two hours long.
We expect to obtain high quality proton and/or phosphorous spectroscopy imaging from healthy volunteers that will help establish accurate and reliable spectroscopy methods for clinical investigators to perform non-invasive studies of psychiatric, neurological disorders, and other diseases in human brain or muscle.
Details
| Condition | Brain Mapping, Healthy Volunteer |
|---|---|
| Treatment | MAGNETOM 7 Tesla scanner, 1Tx32Rx head coil, Phosphorous (31P) surface coils, NSR MAGNETOM 7T, 1Tx x 32Rx Head Coil |
| Clinical Study Identifier | NCT01266577 |
| Sponsor | National Institute of Mental Health (NIMH) |
| Last Modified on | 11 September 2023 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer